ORIC Pharmaceuticals Ownership | Who Owns ORIC Pharmaceuticals?

Overview Forecast RevenueFinancials Chart

ORIC Pharmaceuticals Ownership Summary

ORIC Pharmaceuticals is owned by 119.47% institutional investors, 6.94% insiders. Vr adviser is the largest institutional shareholder, holding 8.44% of ORIC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.65% of its assets in ORIC Pharmaceuticals shares.

ORIC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ORIC Pharmaceuticals	119.47%	6.94%	-26.40%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vr adviser	6.60M	8.44%	$66.96M
Viking global investors lp	6.57M	8.41%	$66.71M
Nextech invest	5.29M	7.49%	$42.66M
Blackrock	4.83M	7.17%	$34.15M
Pfizer	5.38M	6.88%	$54.57M
Alkeon capital management	4.50M	5.77%	$45.72M
Nea management company	4.12M	5.27%	$41.80M
Blackrock funding, inc. /de	4.08M	5.22%	$41.39M
Column group	3.54M	5.02%	$28.57M
Ecor1 capital	3.42M	4.85%	$27.58M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	3.54M	51.26%	$28.57M
Pfizer	5.38M	9.47%	$54.57M
Invus financial advisors	1.01M	7.98%	$7.12M
Nextech invest	5.29M	6.92%	$42.66M
Vr adviser	6.60M	5.02%	$66.96M
Superstring capital management lp	344.92K	4.15%	$3.50M
Ally bridge group (ny)	485.63K	4.10%	$4.93M
Silverarc capital management	1.80M	3.37%	$18.28M
Euclidean capital	989.41K	3.28%	$10.04M
Vivo capital	3.13M	3.25%	$31.74M

Top Buyers

Holder	Shares	% Assets	Change
Vr adviser	6.60M	5.02%	3.41M
Point72 asset management	2.85M	0.06%	2.85M
Nea management company	4.12M	3.15%	1.92M
Blackrock	4.83M	0.00%	1.65M
Integral health asset management	1.25M	1.16%	1.25M

Top Sellers

Holder	Shares	% Assets	Change
Commodore capital lp	-	-	-2.00M
Fmr	2.47M	0.00%	-1.91M
Blackrock funding, inc. /de	4.08M	0.00%	-1.36M
Avidity partners management lp	-	-	-1.27M
Ubs asset management americas	-	-	-509.18K

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	2.85M	0.06%	2.85M	$28.93M
Integral health asset management	1.25M	1.16%	1.25M	$12.69M
Eventide asset management	951.43K	0.17%	951.43K	$9.66M
Ally bridge group (ny)	485.63K	4.10%	485.63K	$4.93M
Royce & associates lp	234.77K	0.02%	234.77K	$2.38M

Sold Out

Holder	Change
Capital performance advisors llp	-1.00
Nelson, van denburg & campbell wealth management group	-8.00
True wealth design	-26.00
Coldstream capital management	-45.00
Parkside financial bank & trust	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	143	-0.69%	93,335,020	17.83%	119	0.96%	75	-8.54%	52	36.84%
Mar 31, 2025	11	-91.91%	11,102,130	-85.35%	15	0.14%	8	-89.87%	2	-92.86%
Dec 31, 2024	39	-68.29%	10,134,721	-85.49%	14	0.15%	26	-58.06%	7	-81.58%
Sep 30, 2024	123	10.81%	69,828,652	3.33%	98	0.98%	62	-16.22%	38	100.00%
Jun 30, 2024	111	-2.63%	67,581,249	5.85%	100	1.12%	74	10.45%	19	-32.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.88M	2.65%	-
ACAP Strategic A	1.98M	2.33%	61.06K
Vanguard Total Stock Mkt Idx Inv	1.90M	2.20%	-42.04K
Fidelity Growth Compy Commingled Pl O	1.28M	1.81%	-
Fidelity Growth Compy Commingled Pl S	1.31M	1.54%	1.10K
iShares Russell 2000 ETF	1.07M	1.26%	-20.37K
T. Rowe Price Health Sciences	1.03M	1.21%	-38.72K
T. Rowe Price New Horizons	914.12K	1.07%	334.92K
US Small-Cap Growth II Equity Comp	914.12K	1.07%	914.12K
Fidelity Growth Company Fund	727.74K	0.85%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 01, 2025	Piscitelli Dominic	Chief Financial Officer	Sell	$200.97K
Jun 24, 2025	Piscitelli Dominic	Chief Financial Officer	Sell	$341.04K
Jun 23, 2025	Piscitelli Dominic	Chief Financial Officer	Sell	$4.50K
Jun 23, 2025	Piscitelli Dominic	Chief Financial Officer	Sell	$5.84K
Jun 23, 2025	You Angie	-	Buy	$13.23K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	1
2025 Q2	2	9
2025 Q1	-	-
2024 Q4	-	3
2024 Q2	-	-

ORIC Ownership FAQ

Who Owns ORIC Pharmaceuticals?

ORIC Pharmaceuticals shareholders are primarily institutional investors at 119.47%, followed by 6.94% insiders and -26.41% retail investors. The average institutional ownership in ORIC Pharmaceuticals's industry, Biotech Stocks , is 304.14%, which ORIC Pharmaceuticals falls below.

Who owns the most shares of ORIC Pharmaceuticals?

ORIC Pharmaceuticals’s largest shareholders are Vr adviser (6.6M shares, 8.44%), Viking global investors lp (6.57M shares, 8.41%), and Nextech invest (5.29M shares, 7.49%). Together, they hold 24.35% of ORIC Pharmaceuticals’s total shares outstanding.

Does Blackrock own ORIC Pharmaceuticals?

Yes, BlackRock owns 7.17% of ORIC Pharmaceuticals, totaling 4.83M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.15M$. In the last quarter, BlackRock increased its holdings by 1.65M shares, a 52.00% change.

Who is ORIC Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Column group is ORIC Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 51.26% of its assets in 3.54M ORIC Pharmaceuticals shares, valued at 28.57M$.

Who is the top mutual fund holder of ORIC Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of ORIC Pharmaceuticals shares, with 2.65% of its total shares outstanding invested in 1.88M ORIC Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools